EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Plasma Protein Panel for Assessing the Risk of Alzheimer’s Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts

Polina A Strelnikova iD, Alexey S Kononikhin iD, Natalia V Zakharova iD, Anna E Bugrova iD, Maria I Indeykina iD, Yana B Fedorova iD, Igor V Kolykhalov, Anna Y Morozova, Alisa V Andryushchenko, Elena D Fedoseeva iD, Marina A Emelyanova, Dmitry A Gryadunov iD und 6 weitere

International Journal of Molecular Sciences · 2025

DOI: 10.3390/ijms27010015 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Molecular Sciences, 2025. Verfasst von Polina A Strelnikova und 17 weiteren Autor:innen. Beteiligte Einrichtung: Project Center of Omics Technologies and Advanced Mass Spectrometry, 121205 Moscow, Russia. Hauptthemen laut MEDLINE: Alzheimer Disease, Blood Proteins, Proteomics, Mass Spectrometry. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 45 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministry of Science and Higher Education of the Russian Federation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Early recognition of a risk of Alzheimer’s disease (AD) remains a global challenge, and blood proteomic markers are of particular interest for wide-scale diagnostic use. Quantitative multiple reaction monitoring (MRM) approach demonstrates good reproducibility in the characteristic changes in the levels of reported candidate biomarkers (CBs) in different cohorts in AD. Following up on our previous study, we performed a joint analysis of 331 blood plasma samples from two different clinical cohorts of participants, comprising a total of 95 samples from patients with AD, 136 samples from patients with mild cognitive impairment (MCI), and 100 samples from controls. The obtained results confirm the significance of 37 CBs. A logistic regression-based algorithm was used to build protein classifiers, and a total of 21 important proteins were selected, 13 of which (ORM1, APOA4, LBP, HP, FN1, BCHE, APOE, PZP, A1BG, TF, SERPINA7, TTR, and F12) formed a universal panel that demonstrated strong classification performance in distinguishing AD patients from controls (ROC-AUC = 0.90) and in separating stable and progressing patients with MCI (ROC-AUC = 0.81). Overall, the analysis confirms the high potential of the MRM method for validating CBs in independent cohorts.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseBlood ProteinsProteomicsMass SpectrometryHumansBiomarkersFemaleAgedCognitive DysfunctionMaleCohort StudiesReproducibility of Results

Stichwörter der Autor:innen

Alzheimer’s diseasebiomarkersbloodmass-spectrometrymild cognitive impairmentproteinsproteomics

Substanzen

BiomarkersBlood Proteins

Autor:innen und Institutionen

  • Project Center of Omics Technologies and Advanced Mass Spectrometry, 121205 Moscow, Russia.
  • Emanuel Institute for Biochemical Physics, Russian Academy of Sciences, 119334 Moscow, Russia.
  • Mental Health Research Center, 115522 Moscow, Russia.
  • Russian Medical Academy of Postgraduate Education, Ministry of Healthcare of the Russian Federation, 125993 Moscow, Russia.
  • Mental-Health Clinic No. 1 Named After N.A. Alexeev of Moscow Healthcare Department, 117152 Moscow, Russia.
  • Department of Mental Health, Faculty of Psychology, M. V. Lomonosov Moscow State University, 119991 Moscow, Russia.

ORCID-Profile: Polina A Strelnikova, Alexey S Kononikhin, Natalia V Zakharova, Anna E Bugrova, Maria I Indeykina, Yana B Fedorova, Elena D Fedoseeva, Dmitry A Gryadunov, Vladimir A Mitkevich, George P Kostyuk

Förderung

  • Ministry of Science and Higher Education of the Russian Federation

Zitieren

APA

Strelnikova, P. A., Kononikhin, A. S., Zakharova, N. V., Bugrova, A. E., Indeykina, M. I., Fedorova, Y. B., Kolykhalov, I. V., Morozova, A. Y., Andryushchenko, A. V., Fedoseeva, E. D., Emelyanova, M. A., Gryadunov, D. A., Gavrilova, S. I., Mitkevich, V. A., Kostyuk, G. P., Chaika, Y. A., Makarov, A. A., & Nikolaev, E. N. (2025). Plasma Protein Panel for Assessing the Risk of Alzheimer’s Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts. International Journal of Molecular Sciences. https://doi.org/10.3390/ijms27010015

Vancouver

Strelnikova PA, Kononikhin AS, Zakharova NV, Bugrova AE, Indeykina MI, Fedorova YB, et al. Plasma Protein Panel for Assessing the Risk of Alzheimer’s Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts. International Journal of Molecular Sciences. 2025. doi:10.3390/ijms27010015

BibTeX
@article{Strelnikova2025,
  author = {Strelnikova, Polina A and Kononikhin, Alexey S and Zakharova, Natalia V and Bugrova, Anna E and Indeykina, Maria I and Fedorova, Yana B and Kolykhalov, Igor V and Morozova, Anna Y and Andryushchenko, Alisa V and Fedoseeva, Elena D and Emelyanova, Marina A and Gryadunov, Dmitry A and Gavrilova, Svetlana I and Mitkevich, Vladimir A and Kostyuk, George P and Chaika, Yulia A and Makarov, Alexander A and Nikolaev, Evgeny N},
  title = {Plasma Protein Panel for Assessing the Risk of Alzheimer’s Disease by MRM-MS Analysis: The Study of Two Independent Clinical Cohorts},
  journal = {International Journal of Molecular Sciences},
  year = {2025},
  doi = {10.3390/ijms27010015}
}
Kostenlos starten →